Prospective Subgroup Analyses of the Randomized Mcl-002 (Sprint) Study: Lenalidomide Versus Investigator's Choice in Relapsed or Refractory Mantle Cell Lymphoma
AuthID
P-00N-GM2
P-00N-GM2
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service